Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma

Human Pathology

Volumn 42, Issue 2, 2011, Pages 185-193

  Velasco, Ana ^a   Pallares, Judit ^a   Santacana, Maria ^a   Gatius, Sonia ^a   Fernandez, Melisa ^a   Domingo, Monica ^a   Valls, Joan ^a   Yeramian, Andree ^a   Encinas, Mario ^a   Dolcet, Xavier ^a   Matias Guiu, Xavier ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

Endometrial carcinoma; Promoter hypermethylation; Sprouty2; Tissue microarray

Indexed keywords

BETA CATENIN; K RAS PROTEIN; KI 67 ANTIGEN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; SPROUTY PROTEIN; SPROUTY PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY;

ADENOCARCINOMA; DNA METHYLATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENE SILENCING; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC; TISSUE ARRAY ANALYSIS;

EID: 78751585102     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.08.001     Document Type: Article

References (29)

1. Bockman J.V. Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 1983 10 17
2. Matias-Guiu X., Catasus L., and Bussaglia E. Molecular pathology of endometrial hyperplasia and carcinoma Hum Pathol 32 2001 569 577
3. Catasús L.l., Machín P., Matias-Guiu X., and Prat J. Microsatellite instability in endometrial carcinomas. Clinico-pathologic correlations in a series of 42 cases Hum Pathol 29 1998 1160 1164
4. Bussaglia E., del Rio E., Matias-Guiu X., and Prat J. PTEN mutations in endometrial carcinomas. A molecular and clinicopathologic analysis of 38 cases Hum Pathol 31 2000 312 317
5. Velasco A., Bussaglia E., and Pallares J. PIK3CA gene mutations in endometrial carcinoma Hum Pathol 37 2006 1465 1472
6. Lagarda H., Catasus L.l., Argüelles R.M., Matias-Guiu X., and Prat J. k-RAS mutations in endometrial carcinomas with microsatellite instability J Pathol 193 2001 193 199
7. Machin P., Catasus L., Pons C., Muñoz J., Matias-Guiu X., and Prat J. CTNNB1 mutations and beta-catenin expression in endometrial carcinomas Hum Pathol 33 2002 206 212
8. Moreno-Bueno G., Hardisson D., and Prat J. Abnormalities of the APC/beta-catenin pathway in endometrial cancer Oncogene 21 2002 7981 7990
9. Prat J., Oliva E., Lerma E., Vaquero M., and Matias Guiu X. Uterine papillary serous adenocarcinoma. A 10 case study of p53 and c-erbB 2 expression and DNA content Cancer 74 1994 1778 1783
10. Pollock P.M., Gartside M.G., and Dejeza L.C. Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes Oncogene 26 2007 7158 7162
11. Pallarés J., Velasco A., and Eritja N. Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma Mod Pathol 21 2008 691 699
12. Kim H.J., and Bar-Sagi D. Modulation of signaling by sprouty: a developing story Mol Cell Biology 5 2004 441 450
13. Fritzsche S., M. Kenzelmann, and Hofmann M.J. Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma Endocr Relat Cancer 13 2006 839 849
14. Lo T.L., Fong C.W., and Yusoff P. Sprouty and cancer: the first terms report Cancer Lett 2006 1 10
15. McKie A.B., Douglas D.A., and Olijslagers S Graham J. Epigenetic inactivation of the human sprouty2 homologue in prostate cancer Oncogene 24 2005 2166 2174
16. Lo T.L., Yussof P., and Fong C.W. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer Cancer Res 64 2004 6127 6136
17. Sutterlüty H., Mayer C.E., and Setinek U. Down-regulation of sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms Mol Cancer Res 5 2007 509 520
18. Fong C.W., Chua M.S., and McKie A. Sprouty2, and inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma Cancer Res 66 2006 2048 2058
19. Hacohen N., Kramer S., Sutherland D., Hiromi Y., and Krasnow M.A. Sprouty encodes a novel antagonist of FGF signalling that patterns apical branching of the Drosophila airways Cell 92 1998 253 263
20. Su A.I., Cooke M.P., and Ching K.A. Large-scale analysis of the human and mouse transcriptomes Proc Natl Acad Sci U S A 99 2002 4465 4470
21. Ozaki K., Kadomoto R., Asato K., Tanimura S., Itoh N., and Kohno M. ERK pathway positively regulates the expression of Sprouty genes Biochem Biophys Res Commun 285 2001 1084 1088
22. Abe M., and Naski M.C. Regulation of sprouty expression by PLC gamma and calcium-dependent signals Biochem Biophys Res Commun 323 2004 1040 1047
23. Ding W., Bellusci S., Shi W., and Warburton D. Functional analysis of the human Sprouty2 gene promoter Gene 322 2003 175 185
24. Velasco A., Pallares J., and Santacana M. Loss of heterozygosity in endometrial carcinoma Int J Gynecol Pathol 27 2008 305 317
25. Fujino T., Risinger J.I., Collins N.K., Liu F.S., Nishii H., Takahashi H., Westphal E.M., Barrett J.C., Sasaki H., and Kohler M.F. Allelotype of endometrial carcinoma Cancer Res 54 1994 4294 4298
26. Guida M., Sanguedolce F., and Bufo P. Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign, premalignant and malignant endometrial lesions Eur J Gynaecol Oncol 30 2009 267 270
27. Moreno-Bueno G., Hardisson D., and Sanchez C. Abnormalities of the APC/beta-catenin pathway in endometrial cancer Oncogene 21 2002 7981 7990
28. Salvesen HB, MacDonald N, and Ryan A. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma Int J Cancer 91 2006 22 26
29. Arafa M., Kridelka F., and Mathias V. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma Histopathology 53 2008 525 532